Madison Asset Management, LLC Gilead Sciences, Inc. Transaction History

Madison Asset Management, LLC

$7.42 Billion
Q2 2024

A detailed history of Madison Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Madison Asset Management, LLC holds 31,680 shares of GILD stock, worth $2.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

31,680

Previous 31,680 -0.0%

Holding current value

$2.67 Million

Previous $2.32 Million 6.34%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $1.73 Million - $2.11 Million	-24,219 Reduced 43.33%	31,680 $2.32 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $586,892 - $665,550	8,010 Added 16.73%	55,899 $4.53 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $3.23 Million - $3.52 Million	43,635 Added 1025.74%	47,889 $3.59 Million
Q2 2023 Aug 01, 2023	SELL	$76.01 - $86.7 $263,754 - $300,849	-3,470 Reduced 44.92%	4,254 $327,000
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $185,930 - $211,832	-2,405 Reduced 23.74%	7,724 $640,000
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $6.95 Million - $9.97 Million	-111,483 Reduced 91.67%	10,129 $870,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $7,442 - $8,501	-125 Reduced 0.1%	121,612 $7.5 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $427,878 - $481,919	7,413 Added 6.48%	121,737 $7.53 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $39,964 - $50,080	-690 Reduced 0.6%	114,324 $6.8 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $389,604 - $442,208	-6,005 Reduced 4.96%	115,014 $8.35 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $5,482 - $5,915	-81 Reduced 0.07%	121,019 $8.45 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $1.52 Million - $1.66 Million	23,965 Added 24.67%	121,100 $8.34 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $27,418 - $31,242	-484 Reduced 0.5%	97,135 $5.66 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $7.16 Million - $9 Million	-115,255 Reduced 54.14%	97,619 $6.17 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $3.46 Million - $4.02 Million	47,858 Added 29.0%	212,874 $16.4 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $5.79 Million - $7.41 Million	92,416 Added 127.29%	165,016 $12.3 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $4.47 Million - $4.92 Million	72,600 New	72,600 $4.72 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Madison Asset Management, LLC with notifications on news.

Account

Madison Asset Management, LLC Gilead Sciences, Inc. Transaction History